<DOC>
	<DOCNO>NCT00159237</DOCNO>
	<brief_summary>T.to investigate possible mechanism glucocorticosteroid receptor ( GR ) defect patient severe COPD study effect dexamethasone ( Dex ) GR- binding , interleukin production ( IL-6/IL-8 ) MKP-1 expression peripheral blood mononuclear cell blood ( PBMC )</brief_summary>
	<brief_title>GR Defect Peripheral Blood Mononuclear Cells COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Patients severe ( stage III , Gold ) severe ( stage IV , GOLD ) COPD subject healthy smoker subject nonsmoker Written inform consent Current upper respiratory tract infection Any significant disease disorder ( e.g . cardiovascular , pulmonary ( asthma ) , gastrointestinal , liver , renal , neurological , musculoskeletal , endocrine , metabolic , malignant , psychiatric , major physical impairment ) , opinion investigator , may either put subject risk participation study , may influence result study , subject ability participate study Subjects consider capable , judged investigator , follow instruction study , e.g . history alcohol drug abuse reason</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>August 2008</verification_date>
</DOC>